Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered as a streamlined evaluation by the lead team of committee D, which includes the chair, vice chair and lead team.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

Chair

Dr Megan John
Chair, technology appraisal committee D

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager and an associate director.

Alice Bell
Technical lead

Alan Moore
Technical adviser

Leena Issa
Project manager

Lorna Dunning
Associate director

ISBN: 978-1-4731-7053-7